Dennis Holmes, MD is an internationally renowned breast cancer, surgeon, surgeon educator, and cancer researcher specializing in the management of breast cancer. Dr. Holmes is medical director of the Sam and Grace Carvajal Comprehensive Breast Center at Adventist Health Glendale in Los Angeles, CA. He is also Co-Founder and CEO of XpediteMD, Inc., a digital health technology company working to improve the efficiency, quality, and value of cancer care.
Dr. Holmes completed his medical education at Tulane University School of Medicine, surgical residency in general surgery at the University of San Francisco, and a fellowship in breast surgery at the University of Southern California.
Dr. Holmes is a board-certified Fellow of the American College of Surgeons and recently served as Program Chair of the 20th Annual National Meeting of the American Society of Breast Surgeons and is the 2023 Health Policy Scholar for the American College of Surgeons. His has also played a pivotal role in several breast cancer treatment innovations, including cryoablation or tumor freezing as an alternative to surgery.
Dr. Holmes is part of an international effort to make cryoablation more widely available to women. He is the Principal Investigator of the ongoing DCIS Cryoablation clinical trial and has developed techniques for treating advanced breast cancer with cryoablation.